Prolactin and inflammation in Parkinson's severity
Part of Brain & nervous system clinical trials.
This study looks at whether prolactin (a hormone) and inflammation markers in blood and saliva are related to the severity of Parkinson's disease. It may help identify new ways to track the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with idiopathic Parkinson's disease by a neurologist (not another form of parkinsonism)
- You are male or a woman who has gone through menopause (postmenopausal)
- You are stable enough to provide blood and saliva samples and undergo a neurological exam
- You do not have an active infection, chronic inflammatory disease, or cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny molecules called miRNAs and signs of inflammation in people with both Parkinson's disease and healthy gums. The goal is to understand how gum health might relate to Parkinson's. It is for people with Parkinson's who have no other major health conditions and have not had recent gum treatments or certain medications.
This study examines changes in alpha-synuclein, a protein linked to Parkinson's, to better understand how the disease progresses. It may help researchers learn more about Parkinson's and improve future care.
This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.
This study uses special brain scans (PET/MR) to see inflammation in people with Parkinson’s disease or related conditions. It may help researchers better understand what drives symptoms and how inflammation changes in the brain.
This study uses a special PET scan to look for signs of brain inflammation in people with Parkinson's disease. It aims to understand how inflammation relates to Parkinson's and may help in developing new treatments.
This study looks at how changes in estrogen before diagnosis affect the growth of prolactin-secreting pituitary tumors (prolactinomas). The goal is to understand why some tumors are larger than others.
Hear when a new Idiopathic Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.